Literature DB >> 18523248

Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages.

Lisa N Henning1, Abul K Azad, Kishore V L Parsa, Joy E Crowther, Susheela Tridandapani, Larry S Schlesinger.   

Abstract

The pulmonary innate immune system responds to various airborne microbes. Although its specificity is broad and based on the recognition of pathogen-associated molecular patterns, it is uniquely regulated to limit inflammation and thereby prevent damage to the gas-exchanging alveoli. Macrophages, critical cell determinants of this system, recognize microbes through pattern recognition receptors such as TLRs, which typically mediate proinflammatory responses. The lung collectin, surfactant protein A (SP-A), has emerged as an important innate immune determinant that regulates microbe-macrophage interactions in this environment. In this study, we report the basal and SP-A-induced transcriptional and posttranslational regulation of TLR2 and TLR4 expression during the differentiation of primary human monocytes into macrophages. Despite SP-A's ability to up-regulate TLR2 expression on human macrophages, it dampens TLR2 and TLR4 signaling in these cells. SP-A decreases the phosphorylation of IkappaBalpha, a key regulator of NF-kappaB activity, and nuclear translocation of p65 which result in diminished TNF-alpha secretion in response to TLR ligands. SP-A also reduces the phosphorylation of TLR signaling proteins upstream of NF-kappaB, including members of the MAPK family. Finally, we report for the first time that SP-A decreases the phosphorylation of Akt, a major cell regulator of NF-kappaB and potentially MAPKs. These data identify a critical role for SP-A in modulating the lung inflammatory response by regulating macrophage TLR activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523248      PMCID: PMC2562757          DOI: 10.4049/jimmunol.180.12.7847

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

4.  By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

Authors:  Shyra J Gardai; Yi-Qun Xiao; Matthew Dickinson; Jerry A Nick; Dennis R Voelker; Kelly E Greene; Peter M Henson
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

5.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity.

Authors:  Alison A Beharka; Joy E Crowther; Francis X McCormack; Gerene M Denning; Jason Lees; Eric Tibesar; Larry S Schlesinger
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

7.  Human Toll-like receptor 4 recognizes host-specific LPS modifications.

Authors:  Adeline M Hajjar; Robert K Ernst; Jeff H Tsai; Christopher B Wilson; Samuel I Miller
Journal:  Nat Immunol       Date:  2002-03-25       Impact factor: 25.606

8.  Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages.

Authors:  J C McIntosh; S Mervin-Blake; E Conner; J R Wright
Journal:  Am J Physiol       Date:  1996-08

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A.

Authors:  Koji Kuronuma; Hitomi Sano; Kazunori Kato; Kazumi Kudo; Naoki Hyakushima; Shin-ichi Yokota; Hiroki Takahashi; Nobuhiro Fujii; Hiroshi Suzuki; Tatsuhiko Kodama; Shosaku Abe; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

View more
  71 in total

1.  Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways.

Authors:  Thomas Kampfrath; Andrei Maiseyeu; Zhekang Ying; Zubair Shah; Jeffrey A Deiuliis; Xiaohua Xu; Nisharahmed Kherada; Robert D Brook; Kongara M Reddy; Nitin P Padture; Sampath Parthasarathy; Lung Chi Chen; Susan Moffatt-Bruce; Qinghua Sun; Henning Morawietz; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2011-01-27       Impact factor: 17.367

2.  Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy.

Authors:  Deug-Chan Lee; Roberto Romero; Chong Jai Kim; Tinnakorn Chaiworapongsa; Adi L Tarca; JoonHo Lee; Yeon-Lim Suh; Shali Mazaki-Tovi; Edi Vaisbuch; Pooja Mittal; Sorin Draghici; Offer Erez; Juan Pedro Kusanovic; Sonia S Hassan; Jung-Sun Kim
Journal:  J Immunol       Date:  2010-05-03       Impact factor: 5.422

3.  Editorial: CD8 T cells cut back on calcium intake in the lungs.

Authors:  Ross B Fulton; Steven M Varga
Journal:  J Leukoc Biol       Date:  2010-06       Impact factor: 4.962

4.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

5.  A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway.

Authors:  Ryan P Nolan; Andrea G Bree; Anup Zutshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-09-26       Impact factor: 2.745

6.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages.

Authors:  Michelle N Brooks; Murugesan V S Rajaram; Abul K Azad; Amal O Amer; Martin A Valdivia-Arenas; Jong-Hwan Park; Gabriel Núñez; Larry S Schlesinger
Journal:  Cell Microbiol       Date:  2010-11-24       Impact factor: 3.715

7.  Molecular composition of the alveolar lining fluid in the aging lung.

Authors:  Juan I Moliva; Murugesan V S Rajaram; Sabeen Sidiki; Smitha J Sasindran; Evelyn Guirado; Xueliang Jeff Pan; Shu-Hua Wang; Patrick Ross; William P Lafuse; Larry S Schlesinger; Joanne Turner; Jordi B Torrelles
Journal:  Age (Dordr)       Date:  2014-03-03

Review 8.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

9.  Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.

Authors:  Atsushi Mitsuhashi; Hisatsugu Goto; Takuya Kuramoto; Sho Tabata; Sawaka Yukishige; Shinji Abe; Masaki Hanibuchi; Soji Kakiuchi; Atsuro Saijo; Yoshinori Aono; Hisanori Uehara; Seiji Yano; Julie G Ledford; Saburo Sone; Yasuhiko Nishioka
Journal:  Am J Pathol       Date:  2013-03-14       Impact factor: 4.307

Review 10.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.